Bridgehead establishes collaboration in Turkey
Emrah Aras MD is a specialist in Market Access, Business Development and Medical Management. His recent consultancy experience has included:
- Providing solutions to various pharma companies from market access to life cycle management
- Preparing reimbursement dossiers
- Providing services of pharmacoeconomics, including arguments
- Conducting face-to-face Reimbursement Committee meetings with, or on behalf of, clients
- Organising related seminars and training programs.
Prior to becoming a consultant, Dr Aras was Health Economics Manager for Sanofi-aventis in Turkey. During his time with Sanofi-aventis, he initiated and managed pharmacoeconomics studies, prepared reimbursement dossiers, lobbied reimbursement agencies – including the Ministry of Finance, Ministry of Health, Ministry of Labor, Undersecretary of Treasury and related commissions – and managed lobbying activities to reimbursement bureaucrats and Health Commission Members. In addition, he was a member of the Product Development Team for Low Molecular Weight Heparin at corporate level and gained experience of medico-marketing.
Dr Aras is a medical doctor and holds a Masters degree in Healthcare Administration, as well as Masters of Business Administration. He lectures regularly on reimbursement and pharmacoeconomic topics.
Seyfullah Dagistanli MD, PhD
Seyfullah Dagistanli MD, PhD is Managing Partner of VG-FAR. VG-FAR provides services to pharmaceutical companies in business development, registration, reimbursement, and pharma regulations.
VG-FAR has registered 21 products since 2006, while managing public affairs and relations with medical associations. VG-FAR has successfully conducted 14 product reimbursement approvals during the last two years.
Dr Dagistanli has worked within the pharmaceutical industry as Medical Director and Consultant for EUCAN II Region for Schering-Plough Corporation Scientific Director and Advisor for Pharmacovigilance and Clinical Trials for AESCA Corporation.
Previously, he has held very senior government posts, including:
- Quality Control Department Head 2002–2006; Ministry of Health, Pharmaceutical Affairs
- Registration Department Head 2000–2002; Ministry of Health, Pharmaceutical Affairs Drug, Pharmacy and Cosmetic Departments
- Representative of Turkey, Ministry of Health 2001–2005: World Health Organization, World Trade Organization, European Union Enlargement Negotiations and Meetings.
Dr Dagistanli is a medical doctor, with a PhD in Pharmaceutical Toxicology. He is Founder and President of the Pharmacovigilance Association of Turkey and Founder and Member of the Clinical Research Association of Turkey. He is editor of the GCP Journal and author of many articles on GCP, GMP, Pharmacovigilance, Pharmacoeconomics, Registration and Quality Control of Pharmaceuticals, patent and data exclusivity.
